top of page

Exploring the Potential of Psychedelics in Eating Disorder Treatment


In recent years, there has been a growing interest in the potential therapeutic applications of psychedelics for various mental health conditions. This abstract aims to summarize a study that investigates the use of psychedelics in the treatment of eating disorders (ED) and its outcomes. The study examines six peer-reviewed articles reporting the usage of ayahuasca, DMT/5-MeO-DMT, LSD/1P-LSD, San Pedro/mescaline, psilocybin, and ketamine by individuals with ED.


The findings from these studies indicate that participants reported positive outcomes following their psychedelic experiences. Many individuals experienced a reduction in ED symptoms, decreased anxiety levels, and improvements in depression, wellbeing, and self-perception. Some even achieved complete remission of their eating disorders. Additionally, participants reported profound spiritual healing and gained deep insights into the psychological origins of their ED.


While the qualitative studies met all the quality appraisal criteria, the quantitative studies had varying ratings between 20% and 60%. Therefore, more rigorous research, such as randomized controlled trials, is needed to establish the efficacy and long-term implications of psychedelic-assisted psychotherapy for eating disorders.


The study concludes that the preliminary findings suggest the therapeutic potential of psychedelics in the treatment of eating disorders. However, it emphasizes the urgency for major changes in drug policy to facilitate further research in this area. Randomized controlled trials are crucial in validating the effectiveness of psychedelic-assisted psychotherapy and determining its suitability as a long-term treatment option for eating disorders.


In conclusion, this research sheds light on the promising role of psychedelics in the field of mental health, specifically in treating eating disorders. While further investigations are necessary, these preliminary findings open up new possibilities for innovative treatment approaches and highlight the need for supportive drug policies to drive further research in this exciting area of study.


1 view0 comments

Bình luận

Đã xếp hạng 0/5 sao.
Chưa có xếp hạng

Thêm điểm xếp hạng
bottom of page